Roy to controversial HIV drugmaker: “I hope you make a lot of money”
“Truvada” is a name-brand drug that can treat and reduce the risk of HIV infection.
In some countries, a similar drug costs about $60 a year. For Americans with HIV, it can cost $20,000 a year.
To Congressman Chip Roy (TX-21), that seems fair. Patriotic, even.
At today’s House Oversight Committee hearing, drug company executives and medical experts answered questions surrounding how one drug has generated $36 billion in revenues for a pharmaceutical company since 2004.
As wealthy drugmakers faced scrutiny, Congressman Roy had a meltdown.
“In case Congressman Roy’s priorities weren’t already crystal clear, he spent a hearing today openly celebrating big pharmaceutical companies as they price gouge hardworking Texas families,” DCCC Spokesperson Avery Jaffe said. “After taking thousands of dollars from people in the pharmaceutical industry, it’s no wonder Congressman Roy is sucking up to the types of wealthy special interests who fund his campaigns.”